41 related articles for article (PubMed ID: 31604902)
1. Validation of a Multifocal Segmentation Method for Measuring Metabolic Tumor Volume in Hodgkin Lymphoma.
Camacho MR; Etchebehere E; Tardelli N; Delamain MT; Vercosa AFA; Takahashi MES; Brunetto SQ; Metze IGHL; Souza CA; Cerci JJ; Ramos CD
J Nucl Med Technol; 2020 Mar; 48(1):30-35. PubMed ID: 31604902
[TBL] [Abstract][Full Text] [Related]
2. Application of an artificial intelligence-based tool in [
Sachpekidis C; Enqvist O; Ulén J; Kopp-Schneider A; Pan L; Jauch A; Hajiyianni M; John L; Weinhold N; Sauer S; Goldschmidt H; Edenbrandt L; Dimitrakopoulou-Strauss A
Eur J Nucl Med Mol Imaging; 2023 Oct; 50(12):3697-3708. PubMed ID: 37493665
[TBL] [Abstract][Full Text] [Related]
3. A different perspective on PET/CT before treatment in patients with Hodgkin lymphoma: importance of volumetric and dissemination parameters.
Aksu A; Küçüker KA; Solmaz Ş; Turgut B
Ann Hematol; 2024 Mar; 103(3):813-822. PubMed ID: 37964021
[TBL] [Abstract][Full Text] [Related]
4. Reclassifying patients with early-stage Hodgkin lymphoma based on functional radiographic markers at presentation.
Akhtari M; Milgrom SA; Pinnix CC; Reddy JP; Dong W; Smith GL; Mawlawi O; Abou Yehia Z; Gunther J; Osborne EM; Andraos TY; Wogan CF; Rohren E; Garg N; Chuang H; Khoury JD; Oki Y; Fanale M; Dabaja BS
Blood; 2018 Jan; 131(1):84-94. PubMed ID: 29038339
[TBL] [Abstract][Full Text] [Related]
5. Role of volumetric analyses on [
Lopci E; Mascarin M
Expert Rev Hematol; 2023; 16(9):629-631. PubMed ID: 37453051
[No Abstract] [Full Text] [Related]
6. Prognostic value of baseline metabolic tumor volume (MTV) for forecasting chemotherapy outcome in early-stage unfavorable Hodgkin lymphoma: Data from the phase III HD17 trial.
van Heek L; Weindler J; Gorniak C; Kaul H; Müller H; Mettler J; Baues C; Fuchs M; Borchmann P; Ferdinandus J; Dietlein M; Voltin CA; Kobe C; Roth KS
Eur J Haematol; 2023 Dec; 111(6):881-887. PubMed ID: 37644732
[TBL] [Abstract][Full Text] [Related]
7. Automated quantification of baseline imaging PET metrics on FDG PET/CT images of pediatric Hodgkin lymphoma patients.
Weisman AJ; Kim J; Lee I; McCarten KM; Kessel S; Schwartz CL; Kelly KM; Jeraj R; Cho SY; Bradshaw TJ
EJNMMI Phys; 2020 Dec; 7(1):76. PubMed ID: 33315178
[TBL] [Abstract][Full Text] [Related]
8. Metabolic tumour volume in Hodgkin lymphoma-A comparison between manual and AI-based analysis.
Sadik M; Barrington SF; Trägårdh E; Saboury B; Nielsen AL; Jakobsen AL; Gongora JLL; Urdaneta JL; Kumar R; Edenbrandt L
Clin Physiol Funct Imaging; 2024 May; 44(3):220-227. PubMed ID: 38011940
[TBL] [Abstract][Full Text] [Related]
9. Metabolic PET/CT analysis of aggressive Non-Hodgkin lymphoma prior to Axicabtagene Ciloleucel CAR-T infusion: predictors of progressive disease, survival, and toxicity.
Breen WG; Young JR; Hathcock MA; Kowalchuk RO; Thorpe MP; Bansal R; Khurana A; Bennani NN; Paludo J; Bisneto JV; Wang Y; Ansell SM; Peterson JL; Johnston PB; Lester SC; Lin Y
Blood Cancer J; 2023 Aug; 13(1):127. PubMed ID: 37591834
[TBL] [Abstract][Full Text] [Related]
10. Automatic Quantification of Serial PET/CT Images for Pediatric Hodgkin Lymphoma Patients Using a Longitudinally-Aware Segmentation Network.
Tie X; Shin M; Lee C; Perlman SB; Huemann Z; Weisman AJ; Castellino SM; Kelly KM; McCarten KM; Alazraki AL; Hu J; Cho SY; Bradshaw TJ
ArXiv; 2024 Apr; ():. PubMed ID: 38659641
[TBL] [Abstract][Full Text] [Related]
11. PET/CT Reconstruction and Its Impact on [Measures of] Metabolic Tumor Volume.
Knaup H; Weindler J; van Heek L; Voltin CA; Fuchs M; Borchmann P; Dietlein M; Kobe C; Roth K
Acad Radiol; 2023 Dec; ():. PubMed ID: 38155023
[TBL] [Abstract][Full Text] [Related]
12. Need for objective task-based evaluation of AI-based segmentation methods for quantitative PET.
Liu Z; Mhlanga JC; Siegel BA; Jha AK
Proc SPIE Int Soc Opt Eng; 2023 Feb; 12467():. PubMed ID: 37990707
[TBL] [Abstract][Full Text] [Related]
13. Need for objective task-based evaluation of AI-based segmentation methods for quantitative PET.
Liu Z; Mhlanga JC; Siegel BA; Jha AK
ArXiv; 2023 Mar; ():. PubMed ID: 36911274
[TBL] [Abstract][Full Text] [Related]
14. Comparison of different automatic methods for the delineation of the total metabolic tumor volume in I-II stage Hodgkin Lymphoma.
Martín-Saladich Q; Reynés-Llompart G; Sabaté-Llobera A; Palomar-Muñoz A; Domingo-Domènech E; Cortés-Romera M
Sci Rep; 2020 Jul; 10(1):12590. PubMed ID: 32724136
[TBL] [Abstract][Full Text] [Related]
15. Baseline
Triumbari EKA; Gatta R; Maiolo E; De Summa M; Boldrini L; Mayerhoefer ME; Hohaus S; Nardo L; Morland D; Annunziata S
Diagnostics (Basel); 2023 Apr; 13(8):. PubMed ID: 37189492
[TBL] [Abstract][Full Text] [Related]
16. Baseline metabolic tumour burden improves risk stratification in Hodgkin lymphoma: A Children's Oncology Group study.
Milgrom SA; Kim J; Pei Q; Lee I; Hoppe BS; Wu Y; Hodgson D; Kessel S; McCarten KM; Roberts K; Lo AC; Cole PD; Kelly KM; Cho SY
Br J Haematol; 2023 Jun; 201(6):1192-1199. PubMed ID: 36922022
[TBL] [Abstract][Full Text] [Related]
17. A Deep Learning-Aided Automated Method for Calculating Metabolic Tumor Volume in Diffuse Large B-Cell Lymphoma.
Kuker RA; Lehmkuhl D; Kwon D; Zhao W; Lossos IS; Moskowitz CH; Alderuccio JP; Yang F
Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358642
[TBL] [Abstract][Full Text] [Related]
18. The transformational potential of molecular radiomics.
Currie G; Hawk KE; Rohren E
J Med Radiat Sci; 2023 Apr; 70 Suppl 2(Suppl 2):77-88. PubMed ID: 36238997
[TBL] [Abstract][Full Text] [Related]
19. AuNP Aptasensor for Hodgkin Lymphoma Monitoring.
Slyusarenko M; Shalaev S; Valitova A; Zabegina L; Nikiforova N; Nazarova I; Rudakovskaya P; Vorobiev M; Lezov A; Filatova L; Yevlampieva N; Gorin D; Krzhivitsky P; Malek A
Biosensors (Basel); 2022 Jan; 12(1):. PubMed ID: 35049651
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
